Literature DB >> 29209867

Non-specific effects and clusters of women with painful TMD responders and non-responders to LLLT: double-blind randomized clinical trial.

Laís Valencise Magri1,2, Vinícius Almeida Carvalho3, Flávia Cássia Cabral Rodrigues2, César Bataglion2, Christie Ramos Andrade Leite-Panissi4,5,6.   

Abstract

The aim was to analyze the non-specific effects (placebo, spontaneous remission, and regression to the mean) of the low-level laser therapy (LLLT) in women with myofascial pain (painful temporomandibular disorder (TMD)), as well as to differentiate between responders and non-responder clusters to active and placebo LLLT according to the anxiety levels, salivary cortisol, use of oral contraceptives, and premenstrual period. Sixty-four women diagnosed with myofascial pain (Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD)) were included, divided into laser (n = 20), placebo group (n = 21), and 23 controls (without treatment (WT)). The LLLT applied was 780 nm, masseter and temporal = 5 J/cm2 (20 mW-0.5 W/cm2), and TMJ area = 7.5 J/cm2 (30 mW-0.8 W/cm2), eight sessions, twice a week. The pain intensity (visual analogue scale (VAS)), anxiety (Beck Anxiety Inventory), salivary cortisol, and menstrual cycle's data at the baseline, T1-T8, and 30 days after LLLT (follow-up) were evaluated. The laser group showed 80% of pain reduction, placebo 85%, and WT 43% in T8. Women with severe anxiety and at the premenstrual period did not reduce pain with any LLLT. Active and placebo LLLT had similar effectiveness during the treatment period; however, women with moderate anxiety, cortisol levels above 10 ng/ml, and without contraceptive use maintain analgesia longer with active LLLT than placebo (follow-up 30 days). Women with low levels of anxiety, salivary cortisol below 10 ng/ml, and with contraceptive use showed the higher pain reduction. The analgesia promoted by LLLT in women with myofascial pain is a result of non-specific effects during the treatment period, although active LLLT is more effective in maintaining the analgesia after treatment (30 days) for the cluster of women with moderate anxiety, salivary cortisol above 10 ng/ml, and without contraceptive use.

Entities:  

Keywords:  Low-level laser therapy; Myofascial pain syndromes; Pain measurement; Placebo; Temporomandibular joint disorders

Mesh:

Year:  2017        PMID: 29209867     DOI: 10.1007/s10103-017-2406-4

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  34 in total

Review 1.  The placebo-nocebo response: controversies and challenges from clinical and research perspective.

Authors:  Miro Jakovljevic
Journal:  Eur Neuropsychopharmacol       Date:  2013-12-08       Impact factor: 4.600

2.  The Research Diagnostic Criteria for Temporomandibular Disorders. V: methods used to establish and validate revised Axis I diagnostic algorithms.

Authors:  Eric L Schiffman; Richard Ohrbach; Edmond L Truelove; Feng Tai; Gary C Anderson; Wei Pan; Yoly M Gonzalez; Mike T John; Earl Sommers; Thomas List; Ana M Velly; Wenjun Kang; John O Look
Journal:  J Orofac Pain       Date:  2010

Review 3.  Placebo and nocebo effects: a complex interplay between psychological factors and neurochemical networks.

Authors:  Elisa Frisaldi; Alessandro Piedimonte; Fabrizio Benedetti
Journal:  Am J Clin Hypn       Date:  2015-01

4.  Temporomandibular disorder pain is related to the general disposition to be anxious.

Authors:  Daniel R Reissmann; Mike T John; Hartwig Seedorf; Stephan Doering; Oliver Schierz
Journal:  J Oral Facial Pain Headache       Date:  2014

5.  Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis.

Authors:  C Kirschbaum; B M Kudielka; J Gaab; N C Schommer; D H Hellhammer
Journal:  Psychosom Med       Date:  1999 Mar-Apr       Impact factor: 4.312

6.  Effects of low-level laser therapy (GaAs) in an animal model of muscular damage induced by trauma.

Authors:  Paulo Cesar Lock Silveira; Luciano Acordi da Silva; Cleber Aurino Pinho; Priscila Soares De Souza; Merieli Medeiros Ronsani; Debora da Luz Scheffer; Ricardo Aurino Pinho
Journal:  Lasers Med Sci       Date:  2012-03-08       Impact factor: 3.161

7.  Relationship between Personality Traits and Endogenous Analgesia: The Role of Harm Avoidance.

Authors:  Hadas Nahman-Averbuch; David Yarnitsky; Elliot Sprecher; Yelena Granovsky; Michal Granot
Journal:  Pain Pract       Date:  2014-10-29       Impact factor: 3.183

Review 8.  Placebo interventions for all clinical conditions.

Authors:  Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

9.  Development of temporomandibular disorders is associated with greater bodily pain experience.

Authors:  Pei Feng Lim; Shad Smith; Kanokporn Bhalang; Gary D Slade; William Maixner
Journal:  Clin J Pain       Date:  2010-02       Impact factor: 3.442

10.  Zymographic and ultrastructural evaluations after low-level laser irradiation on masseter muscle of HRS/J strain mice.

Authors:  Mamie Mizusaki Iyomasa; Elen Camargo Rizzi; Juliane Caroline Leão; João Paulo Mardegan Issa; Fernando José Dias; Yamba Carla Lara Pereira; Maria José Vieira Fonseca; Fabiana Testa Moura de Carvalho Vicentini; Ii-Sei Watanabe
Journal:  Lasers Med Sci       Date:  2012-07-14       Impact factor: 3.161

View more
  6 in total

1.  Orofacial evaluation of individuals with temporomandibular disorder after LED therapy associated or not of occlusal splint: a randomized double-blind controlled clinical study.

Authors:  Davidson Ribeiro Costa; Diego Rodrigues Pessoa; Vanessa Borelli Seefeldt; David Ribeiro Costa; Daniel Tineu Leite Maia; Thiago Dos Santos Maciel; Brenda Barros Magalhães Mota; Carolina Alves Delpasso; Camila Alves Delpasso Ribeiro; Renata Amadei Nicolau
Journal:  Lasers Med Sci       Date:  2021-02-22       Impact factor: 3.161

2.  Simultaneous red and infrared light-emitting diodes reduced pain in individuals with temporomandibular disorder: a randomized, controlled, double-blind, clinical trial.

Authors:  Dowglas Fernando Magalhães de Sousa; Tainá Caroline Dos Santos Malavazzi; Alessandro Melo Deana; Anna Carolina Ratto Tempestini Horliana; Kristianne Porta Santos Fernandes; Sandra Kalil Bussadori; Raquel Agnelli Mesquita-Ferrari
Journal:  Lasers Med Sci       Date:  2022-06-24       Impact factor: 3.161

3.  Salivary Cortisol Levels and Burning Symptoms in Patients with Burning Mouth Syndrome before and after Low Level Laser Therapy: a Double Blind Controlled Randomized Clinical Trial.

Authors:  Ivana Škrinjar; Božana Lončar Brzak; Valentina Vidranski; Vanja Vučićević Boras; Ana Andabak Rogulj; Božidar Pavelić
Journal:  Acta Stomatol Croat       Date:  2020-03

4.  Photobiomodulation with simultaneous use of red and infrared light emitting diodes in the treatment of temporomandibular disorder: study protocol for a randomized, controlled and double-blind clinical trial.

Authors:  Dowglas Fernando Magalhães de Sousa; Marcela Letícia Leal Gonçalves; Fabiano Politti; Renan Didier de Paula Lovisetto; Kristianne Porta Santos Fernandes; Sandra Kalil Bussadori; Raquel Agnelli Mesquita-Ferrari
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

5.  Effect of photobiomodulation therapy on painful temporomandibular disorders.

Authors:  Adila Aisaiti; Yanli Zhou; Yue Wen; Weina Zhou; Chen Wang; Jing Zhao; Linfeng Yu; Jinglu Zhang; Kelun Wang; Peter Svensson
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

Review 6.  Photobiomodulation and myofascial temporomandibular disorder: Systematic review and meta-analysis followed by cost-effectiveness analysis.

Authors:  Ana-Paula-Taboada Sobral; Sergio-de Sousa Sobral; Thalita-Molinos Campos; Anna-Carolina-Ratto-Tempestini Horliana; Kristianne-Porta-Santos Fernandes; Sandra-Kalil Bussadori; Lara-Jansiski Motta
Journal:  J Clin Exp Dent       Date:  2021-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.